|
2025
|
Invention
|
Compounds and combinations thereof for treating neurological and psychiatric conditions.
Dosage ... |
|
|
Invention
|
Bupropion dosage forms with reduced food and alcohol dosing effects.
This disclosure relates to ... |
|
2024
|
Invention
|
Compounds and combinations thereof for treating neurological and psychiatric conditions.
This di... |
|
|
Invention
|
Bupropion as a modulator of drug activity.
Dosage forms, drug delivery systems, and methods rela... |
|
|
Invention
|
Treatment of depression.
This disclosure relates to administration of a combination of: 1) about... |
|
|
Invention
|
Compounds and combinations thereof for treating neurological and psychiatric conditions. Dosage f... |
|
|
Invention
|
Compounds and combinations thereof for treating neurological and psychiatric conditions. This dis... |
|
|
Invention
|
Combination of dextromethorphan and bupropion for treating depression.
This disclosure relates t... |
|
|
Invention
|
Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextrometh... |
|
|
Invention
|
Combination of dextromethorphan and bupropion for treating depression.
Disclosed herein are meth... |
|
|
Invention
|
Bupropion dosage forms with reduced food and alcohol dosing effects. This disclosure relates to d... |
|
|
Invention
|
Bupropion and dextromethorphan for treating nicotine addiction.
Disclosed herein are methods of ... |
|
|
Invention
|
Method of maintaining remission of depressive symptoms.
Disclosed herein are methods of treating... |
|
2023
|
Invention
|
Bupropion and dextromethorphan for reduction of suicide risk in depression patients.
This disclo... |
|
|
Invention
|
Bupropion as a modulator of drug activity.
Disclosed herein are methods of treating neurological... |
|
|
Invention
|
Bupropion as a modulator of drug activity.
This disclosure relates to administration of a combin... |
|
|
Invention
|
Bupropion as a modulator of drug activity. This disclosure relates to administration of a combina... |
|
|
Invention
|
Combination of dextromethorphan and bupropion for treating depression. This disclosure relates to... |
|
|
Invention
|
Bupropion dosage forms with reduced food and alcohol dosing effects. in vitroin vitro. In some em... |
|
|
Invention
|
Treatment of depression in certain patient populations. This disclosure relates to administration... |
|
|
Invention
|
Compositions for oral administration of zoledronic acid or related compounds for treating disease... |
|
|
Invention
|
Pharmaceutical compositions comprising bupropion and cysteine. This disclosure relates to pharmac... |
